Chambers Review
Provided by Chambers
Corporate/M&A - Asia-Pacific Region
What the Team is Known For
Kirkland & Ellis maintains a leading private equity platform representing the firm's stellar US clients in financial investments in China and further across Asia. The firm is increasingly active on behalf of Asian clients, including sovereign wealth funds, and is also known for its work on M&A transactions, including take-privates, private acquisitions and Hong Kong takeovers. The firm is especially well placed for China-related mandates through its Beijing and Hong Kong offices, and also fields a highly commended India practice.
Strengths
What differentiates them is that they are extremely good at grasping complex deal structures. Their significant experience working in PE in this region allows them to help us understand precedents.
The team has outstanding capabilities, ample deal experience and a good reading of regulators. They are able to explain rules and regulations in a commercial sense.
Work Highlights
Kirkland & Ellis acted for CPP Investments on its AUD24 billion acquisition of AirTrunk, alongside Blackstone, from Macquarie Asset Management and other investors.
Kirkland & Ellis assisted funds advised by Apax Partners and Healthium MedTech with definitive agreements to sell a controlling interest in Healthium to KKR.
Notable practitioners
Joey Chau and Brian Ho are key contacts in Hong Kong, while Srinivas Kaushik is a key contact for India-related matters.